Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Suspended 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3CNS 3Plasma cell 2Other hematologic neoplasm 2Head & Neck 2Genitourinary 2Breast 2Lymphoid 1Dermatologic 1

Conditions

Glioma 2Glioblastoma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Glucose × CNS × Clear all
NCT07091864 2026-05-07

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Mayo Clinic

Phase NA Recruiting
116 enrolled
CNS

Glioblastoma

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Stanford University

Phase 2 Suspended
10 enrolled
CNS

Glioma

NCT06594315 2025-09-18

Assessing Brain Metabolism Using MRS With Deuterated Glucose

University of California, San Francisco

Active not recruiting
80 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡